RU2001128507A - Fertility Improving Compositions - Google Patents

Fertility Improving Compositions

Info

Publication number
RU2001128507A
RU2001128507A RU2001128507/14A RU2001128507A RU2001128507A RU 2001128507 A RU2001128507 A RU 2001128507A RU 2001128507/14 A RU2001128507/14 A RU 2001128507/14A RU 2001128507 A RU2001128507 A RU 2001128507A RU 2001128507 A RU2001128507 A RU 2001128507A
Authority
RU
Russia
Prior art keywords
inhibitor
dipeptidyl peptidase
composition according
infertility
improving compositions
Prior art date
Application number
RU2001128507/14A
Other languages
Russian (ru)
Other versions
RU2246944C2 (en
Inventor
Пьер БРОКА
Original Assignee
Ферринг Бв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906714.2A external-priority patent/GB9906714D0/en
Application filed by Ферринг Бв filed Critical Ферринг Бв
Publication of RU2001128507A publication Critical patent/RU2001128507A/en
Application granted granted Critical
Publication of RU2246944C2 publication Critical patent/RU2246944C2/en

Links

Claims (7)

1. Фармацевтическая композиция, предназначенная для лечения бесплодия или усиления фертильности, отличающаяся тем, что она включает в себя терапевтически эффективное количество ингибитора дипептидилпептидазы IV.1. A pharmaceutical composition for treating infertility or enhancing fertility, characterized in that it comprises a therapeutically effective amount of a dipeptidyl peptidase IV inhibitor. 2. Композиция по п.1, в которой причиной бесплодия является синдром поликистоза яичников.2. The composition according to claim 1, in which the cause of infertility is polycystic ovary syndrome. 3. Композиция по п.1 или 2, в которой ингибитор дипептидилпептидазы IV содержит нитрил аминоацилпирролидина.3. The composition according to claim 1 or 2, in which the dipeptidyl peptidase IV inhibitor comprises aminoacylpyrrolidine nitrile. 4. Композиция по любому из предшествующих пунктов, сформированная для перорального применения.4. The composition according to any one of the preceding paragraphs, formed for oral administration. 5. Композиция по п.4 в виде таблеток или капсул.5. The composition according to claim 4 in the form of tablets or capsules. 6. Применение ингибитора дипептидилпептидазы IV для приготовления терапевтической композиции, предназначенной для лечения бесплодия или усиления фертильности.6. The use of a dipeptidyl peptidase IV inhibitor for the preparation of a therapeutic composition for treating infertility or enhancing fertility. 7. Способ лечения бесплодия или содействия оплодотворению, при котором пациенту вводят фармацевтическую композицию, содержащую ингибитор дипептидилпептидазы IV.7. A method of treating infertility or promoting fertilization, in which a pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor is administered to a patient.
RU2001128507/15A 1999-03-23 2000-03-21 Fertility improving compositions RU2246944C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9906714.2A GB9906714D0 (en) 1999-03-23 1999-03-23 Compositions for improving fertility
GB9906714.2 1999-03-23

Publications (2)

Publication Number Publication Date
RU2001128507A true RU2001128507A (en) 2003-06-27
RU2246944C2 RU2246944C2 (en) 2005-02-27

Family

ID=10850229

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001128507/15A RU2246944C2 (en) 1999-03-23 2000-03-21 Fertility improving compositions

Country Status (29)

Country Link
US (1) US7115650B1 (en)
EP (1) EP1162969B1 (en)
JP (1) JP2002539243A (en)
KR (1) KR100689951B1 (en)
CN (1) CN1196483C (en)
AR (1) AR023129A1 (en)
AT (1) ATE328594T1 (en)
AU (1) AU765912B2 (en)
CA (1) CA2366911C (en)
CZ (1) CZ20013410A3 (en)
DE (1) DE60028552T2 (en)
DK (1) DK1162969T3 (en)
ES (1) ES2265918T3 (en)
GB (1) GB9906714D0 (en)
HK (1) HK1046647B (en)
HU (1) HUP0200410A3 (en)
IL (1) IL145569A0 (en)
MX (1) MXPA01009612A (en)
MY (1) MY135683A (en)
NO (1) NO20014607L (en)
NZ (1) NZ514449A (en)
PL (1) PL195779B1 (en)
PT (1) PT1162969E (en)
RU (1) RU2246944C2 (en)
TR (1) TR200102647T2 (en)
TW (1) TWI244920B (en)
UA (1) UA77644C2 (en)
WO (1) WO2000056296A2 (en)
ZA (1) ZA200108083B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
GB9928330D0 (en) * 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US6512120B1 (en) 2001-03-12 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Methods for the synthesis of densely functionalized pyrrolidine intermediates
GB0109146D0 (en) * 2001-04-11 2001-05-30 Ferring Bv Treatment of type 2 diabetes
HUP0400321A2 (en) 2001-06-27 2004-08-30 Smithkline Beecham Corp. Fluoropyrrolidines as dipeptidyl peptidase inhibitors and pharmaceutical compositions containing them
DE60223920T2 (en) 2001-06-27 2008-11-13 Smithkline Beecham Corp. PYRROLIDINES AS DIPEPTIDYL-PEPTIDASE INHIBITORS
US7183290B2 (en) 2001-06-27 2007-02-27 Smithkline Beecham Corporation Fluoropyrrolidines as dipeptidyl peptidase inhibitors
EP1338595B1 (en) 2002-02-25 2006-05-03 Eisai Co., Ltd. Xanthine derivatives as DPP-IV inhibitors
US6710040B1 (en) 2002-06-04 2004-03-23 Pfizer Inc. Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
EP1514552A4 (en) 2002-06-06 2008-04-02 Eisai R&D Man Co Ltd Novel fused imidazole derivative
WO2005026114A1 (en) * 2003-09-17 2005-03-24 Pfizer Inc. Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses
DOP2006000008A (en) 2005-01-10 2006-08-31 Arena Pharm Inc COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
CA2622472C (en) 2005-09-14 2013-11-19 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
CN101360723A (en) 2005-09-16 2009-02-04 武田药品工业株式会社 Process for the preparation of pyrimidinedione derivatives
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
PE20071221A1 (en) 2006-04-11 2007-12-14 Arena Pharm Inc GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
AR077642A1 (en) 2009-07-09 2011-09-14 Arena Pharm Inc METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
JP2013523819A (en) 2010-04-06 2013-06-17 アリーナ ファーマシューティカルズ， インコーポレイテッド GPR119 receptor modulators and treatment of disorders related thereto
KR101871011B1 (en) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140038889A1 (en) 2011-04-22 2014-02-06 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
CA2979033A1 (en) 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
US11583516B2 (en) * 2016-09-07 2023-02-21 Trustees Of Tufts College Dash inhibitors, and uses related thereto
US11253508B2 (en) 2017-04-03 2022-02-22 Coherus Biosciences, Inc. PPARy agonist for treatment of progressive supranuclear palsy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016339A1 (en) 1990-04-14 1991-10-31 New England Medical Center Hospitals, Inc. Inhibitors of dipeptidyl-aminopeptidase type iv
CA2121369C (en) * 1991-10-22 2003-04-29 William W. Bachovchin Inhibitors of dipeptidyl-aminopeptidase type iv
IL111785A0 (en) * 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Similar Documents

Publication Publication Date Title
RU2001128507A (en) Fertility Improving Compositions
CA2366911A1 (en) Compositions for improving fertility
RU2001128504A (en) Growth promoting compositions
SG146608A1 (en) Rapid dissolution formulation of a calcium receptor-active compound
RU98111594A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN
CA2427227A1 (en) Lactam compound
IL212075A0 (en) Pharmaceutical compositions comprising a combination of a renin inhibitor and at least one therapeutic agent and uses thereof for the manufacture of medicaments for the prevention of, delay of progression of, or treatment of a disease
HUP0303876A3 (en) Preparation of pharmaceutical compositions for treatment of type 2 diabetes using piperidine or tiazolidine, inhibitors of dipeptidyl peptidase iv
DE60231298D1 (en) CAPSAICIN-CONTAINING MISAMENTARY PHARMACEUTICAL COMPOSITIONS
SE0104340D0 (en) New compounds
SE0100568D0 (en) Compounds
UA88270C2 (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes
HUP0301194A2 (en) Pharmaceutical compositions containing combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents and their use for the treatment of diabete mellitus
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
RU2008103617A (en) BISPHOSPHONIC ACIDS INTENDED FOR TREATMENT AND PREVENTION OF OSTEOPOROSIS
HUP0001527A2 (en) Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
AP1745A (en) Pharmaceutical compositions of amlodipine and atorvastatin.
BRPI0413393A (en) fexofenadine, pharmaceutically acceptable composition, antihistamine treatment method, composition, process for preparing fexofenadine and use of fexofenadine
TW200509905A (en) Pharmaceutical compositions of atorvastatin
EA200301040A1 (en) METHOD OF MANUFACTURE OF PHARMACEUTICAL COMPOSITION OF LOW DOSE
SE0102440D0 (en) New compound
SE0100566D0 (en) Compounds
BR0014440A (en) Oral controlled release formulations
SE0000303D0 (en) Novel compounds
SE0101692D0 (en) Compounds